Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Stock Upgrades: Use Your Brain -- Buy Skullcandy


Wall Street ratings agencies set the tone for today's stock market.

On the day it was announced that Fiddler on the Roof is returning to Broadway, Wall Street made sure there was absolutely Zero (Mostel) chance of investors having to plaintively ponder what would happen, "If I were a rich man." It seems we all already are, what with household net worth having just hit a record $80.7 trillion and the S&P 500 Index (INDEXSP:.INX) ending at yet another historic high. (As for that other show-stopper from the musical, "Matchmaker, matchmaker, make me a match" -- not so much. Yentas were beyond broke yesterday after utterly unloved JDate owner Spark Networks (NYSE:LOV) imploded 18.98%.) "He can't have her. I love her," was the legendary lament of Staples' (NASDAQ:SPLS) Snowbot when faced with the prospect of being parted with is amorous scanner-fax-copier. Alas, the winter of discontent for this inanimate object continued apace, with the stock sliding 15.30% in tumbling to a near ten-year trough. In his heyday, Paul Simon wrote much more than silly love songs. Indeed, the '70s saw him even pen an ode to Eastman Kodak (NYSE:KODK), although that stock has seen better days after slumping another 2.02%. One year before writing "Kodachrome," Mr. Simon authored "Me and Julio Down by the Schoolyard," which went "But the press let the story leak. And when the radical priest. Come to get me released. We was all on the cover of Newsweek." So, apparently, is the inventor of Bitcoin. A real hard copy, kids, available on newsstands now. The unlikely return of print must feel like pulp fiction for Verso Paper (NYSE:VRS), whose 14.84% nosedive made it easily the NYSE's poorest performer. And interviewed in the old-school, ink-stained pages of the Wall Street Journal (NASDAQ:NWSA), New York Fed head Bill Dudley said, "It seems to us the economy should be better in 2014 than in was in 2013." Given our central bank's spectacularly spotty soothsaying record, be very afraid.
Today in economics, January consumer credit is expected to contract from the prior month's pace at 3:00 p.m. Eastern. On the corporate front, expect earnings announcements out of Big Lots (NYSE:BIG), Foot Locker (NYSE:FL), and Genesco (NYSE:GCO).
Buckle, Inc. (NYSE:BKE): The retail stock is now Neutral from Sell with a $41 price objective at Janney. Catalysts include a pleasant upside surprise in February same-store-sales, achieved during the depths of winter.
Copa Holdings (NYSE:COPA): UBS increases its investment assessment to Buy from Neutral.

Cross Country (NASDAQ:CCRN): Shares get a Buy-from-Neutral boost at Citigroup.
Grocery StocksSafeway (NYSE:SWY) -- downgraded elsewhere today after being bought -- gets upgraded to Neutral from Sell at UBS, which takes The Fresh Market (NASDAQ:TFM) to Buy from Neutral.
Omnicare (NYSE:OCR): A busy UBS research department raises this stock to Buy from Neutral.
Polycom (NASDAQ:PLCM): Citi moves the equity to Buy from Neutral. Its target price, previously $12.50, increases to $16.
Prudential Financial (NYSE:PRU): Bank of America-Merrill Lynch lifts its fellow financial firm to Buy from Neutral.
Quality Systems (NASDAQ:QSII): Amid a more attractive valuation, FBR Capital moves the healthcare information company to Market Perform from Underperform.
Sirius XM Holdings (NASDAQ:SIRI): The home of shock jock Howard Stern gets an Outperform-from-Neutral hoist at Macquarie.
Skullcandy (NASDAQ:SKUL): Shares, surging some 23.82% as we speak after releasing results, are now Outperform from Market Perform at Northland Capital. The target price also doubles, to $12 from $6.
Teva Pharmaceutical (NYSE:TEVA): Barclays takes TEVA to Overweight from Equal Weight, simultaneously increasing its price objective to $65 from $42.
Also see:

New Stock Coverage: Conatus Pharmaceuticals Isn't Only for Smart Scientists

Stock Downgrades: Dumb Down CliffsNotes Owner Houghton Mifflin Harcourt
< Previous
  • 1
Next >
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Featured Videos